Lynas Rare Earths Faces Crucial Quarterly Test Amid Major Shareholder Exit

Lynas posts surging profits as JPMorgan exits and analysts downgrade, setting a tense stage for its quarterly results amid high valuations and long-term supply contracts.

The upcoming quarterly report from Australian rare earths producer Lynas Rare Earths arrives at a moment of intense market scrutiny. While the company’s operational performance has been stellar, a significant shareholder has exited and analyst sentiment has cooled, setting the stage for a pivotal trading session.

JPMorgan Chase, a major investor, has substantially reduced its stake. A regulatory filing shows that as of April 9, the bank and its subsidiaries no longer hold a substantial interest in Lynas, having exited through securities lending, proprietary trading, and asset management activities. This retreat coincides with a shift in analyst outlook. On April 14, Morgan Stanley downgraded the stock from ‘Overweight’ to ‘Equalweight’, setting a price target of A$20.45, and warned that state-subsidized supply growth could pressure long-term prices. Macquarie followed suit with a downgrade to Hold on the same day. In contrast, Jefferies reaffirmed its buy recommendation on April 12.

This caution stands in stark contrast to the company's powerful financial momentum. For the first half of fiscal 2026, net profit surged to A$80.2 million, a dramatic increase from A$5.9 million in the prior-year period. Revenue jumped 63% to A$413.7 million, while EBITDA quadrupled to A$152.4 million. A recent capital raise has also bolstered the balance sheet, leaving Lynas with a cash pile exceeding one billion dollars.

Such explosive growth has fueled an extraordinary share price run. The stock is up approximately 79% since the start of the calendar year and a staggering 158% over the past twelve months. It closed at €12.85 last Friday, not far from its 52-week high of €13.28. This rally has stretched valuations, with the stock trading at a price-to-sales multiple of 29.1x, compared to around 10x for peers. This leaves little room for disappointment in the quarterly figures due April 21.

Operational milestones provide a solid foundation. Lynas recently began production of samarium oxide ahead of schedule at its Malaysian facility, bringing its portfolio of separated heavy rare earths to three commercial products. The operating license for its Gebeng processing plant in Malaysia has been extended for ten years. A new A$180 million Malaysian plant is slated to process 5,000 tonnes of raw material annually, with full separation of heavy rare earths targeted for late 2027.

Long-term revenue is anchored by major government contracts. The U.S. Department of Defense has a four-year, $96 million agreement for rare earth oxides, guaranteeing a minimum price of $110 per kilogram for neodymium-praseodymium oxide. Japan Australia Rare Earths has extended its supply contract to 2038, with a guaranteed minimum annual volume of 5,000 tonnes and a price floor. A strategic cooperation agreement with South Korea’s LS Eco Energy involves Lynas supplying oxides for a planned plant in Vietnam, with both sides investing roughly A$30 million in each other’s convertible bonds.

Investors will dissect the March quarter report for updates on production rates at the new Kalgoorlie facility in Australia and the ramp-up pace in Malaysia. With the stock showing technical weakness—the Relative Strength Index (RSI) recently dipped to 39, indicating it is approaching oversold territory—the quarterly numbers must justify the premium valuation to sustain the year’s powerful momentum.